Clinical Trial

The Training of Resident Surgeons in Single-Port Thoracoscopic Surgery Wound Position Selection

Study acronym: OpVerse
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated May 14, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
the metaverse system applied to the training of wound location selection for singleport thoracoscopic surgery. The experimental design is two groups of 40 computer tomography located superficially less than 2 cm lung nodule patients, one group uses the metaverse system to let resident physicians simulate the wound position on the digital twin organs of each patient, and the other group does not use it. The investigators will evaluate the surgeon's satisfaction with the surgical wound position and urgicalrelated results (such as surgery time, blood loss, etc.). The investigators expect that the system will help improve the appropriateness of resident physicians' choice of wound location for high-difficulty single-port thoracoscopic surgery, help them cross the first threshold necessary to familiarize themselves with the surgery faster, and accelerate learning.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06524297
Lead Sponsor National Taiwan University Hospital
Conditions Surgical Education
Enrollment 80 participants
Start Date 2025-08-15
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-14